Full Professor(heuristic)

Breast Cancer Treatment Studies · Cancer Research

Compare more Cancer Research professors.

h-index37
i10-index56
Publications157
Citations18,407

Grants

6 total · 4 active

NIH #P01CA281826

WISDOM: A platform to optimize subtype-specific screening and prevention

Active
Amount
$3M–$4M
Period
2024-09-112029-08-31
PIs
2

NIH #P01CA210961

Project 3: Characterization of the biology of non-responders using Imaging and molecular analysis to inform treatment

Active
Amount
$1M–$2M
Period
2017-09-082028-06-30
PIs
1

NIH #P30CA082103

Breast Oncology Program

Active
Amount
$100K–$200K
Period
1999-08-052028-05-31
PIs
1

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

6 total · 4 active

NIH #P01CA281826

WISDOM: A platform to optimize subtype-specific screening and prevention

Active
Amount
$3M–$4M
Period
2024-09-112029-08-31
PIs
2

NIH #P01CA210961

Project 3: Characterization of the biology of non-responders using Imaging and molecular analysis to inform treatment

Active
Amount
$1M–$2M
Period
2017-09-082028-06-30
PIs
1

NIH #P30CA082103

Breast Oncology Program

Active
Amount
$100K–$200K
Period
1999-08-052028-05-31
PIs
1

NIH #R01CA255442

Strategy for combining circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) measures of tumor burden for prediction of response and outcome in neoadjuvant-treated early breast cancer

Active
Amount
$600K–$700K
Period
2020-12-032026-11-30
PIs
3

NIH #U54HG007990

Center for Big Data in Translational Genomics

Amount
$2M–$3M
Period
2014-09-292018-08-31
PIs
3

Awarded at UNIVERSITY OF CALIFORNIA SANTA CRUZ

NIH #U01CA164720

Integrative signaling models to decipher complex cancer phenotypes

Amount
$500K–$600K
Period
2012-08-082017-07-31
PIs
4

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

Recent Public Signals

  1. New paper: ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial (Annals of Surgical Oncology)2025-08-29
  2. New NIH award: WISDOM: A platform to optimize subtype-specific screening and prevention2024-09-11
  3. New NIH award: Strategy for combining circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) measures of tumor burden for prediction of response and outcome in neoadjuvant-treated early breast cancer2020-12-03

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-26

Data may not be current

Find elsewhere

Professor Insights

Career Trajectory